Bausch & Lomb (BLCO) Deferred Taxes (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Deferred Taxes came in at -$21.0 million in Q2 2026, up 80.73% on a YoY basis from -$11.6 million in Q2 2025, and down 75.0% quarter-over-quarter from -$12.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Deferred Taxes (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Deferred Taxes for 6 consecutive years, with -$21.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Deferred Taxes rose 80.73% year-over-year to -$21.0 million; the trailing twelve-month figure through Jun 2026 stood at $26.0 million (up 115.38% YoY), and the FY2025 full-year result was -$32.0 million, down 220.0% from the prior year.
- Deferred Taxes slipped to -$21.0 million in Q2 2026 per BLCO's latest filing, from -$12.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $64.0 million in Q4 2025 and bottomed at -$109.0 million in Q2 2025.
- Historically, Deferred Taxes has averaged -$9.7 million across 5 years, with a median of $500000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Deferred Taxes sank 1350.0% in 2023, then jumped 2900.0% in 2024.
- Over 5 years, Deferred Taxes stood at -$51.0 million in 2022, then jumped by 98.04% to -$1.0 million in 2023, then surged by 2900.0% to $28.0 million in 2024, then surged by 128.57% to $64.0 million in 2025, then slumped by 132.81% to -$21.0 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$21.0 million, -$12.0 million, and $64.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 600,000.00 |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | -21.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.00 Mn |
| Mar 31, 2026 | -12.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -109.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 28.00 Mn |
| Sep 30, 2024 | -106.00 Mn |
| Jun 30, 2024 | 24.00 Mn |
| Mar 31, 2024 | 44.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | -25.00 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | -51.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | -43.00 Mn |
| Dec 31, 2021 | 107.00 Mn |
| Sep 30, 2021 | -11.00 Mn |